Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C
Carolin Lackner, Gerd Struber, Bernadette Liegl, Sebastian Leibl, Petra Ofner, Csilla Bankuti, Bernd Bauer, Rudolf E. Stauber – 24 May 2005 – Liver biopsy is recommended before antiviral treatment, particularly for patients with hepatitis C virus (HCV) genotype 1 infection, but it may cause complications and is limited by sampling error. Several non‐invasive tests comprising routine laboratory parameters (simple fibrosis tests) have been proposed to predict fibrosis in chronic HCV.